Google News – Biotech Funding External News
Biotechnology Articles
Google News – Oncology External News
Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody - Fierce Biotech
Google News – FDA (biotech/pharma) External News
FDA approves Stelara for pediatric ulcerative colitis - thepharmaletter.com
Google News – Clinical Trials External News
Clinical Trials of Potentially ‘Game-Changing’ Immunotherapy Drug for Advanced Prostate Cancer Underway at CU Anschutz Cancer Center - University of Colorado Anschutz
Google News – Pharmaceuticals External News
A biotech is seeking cancer or brain therapies. CNS Pharmaceuticals lays out its plan. - Stock Titan
Google News – Clinical Trials External News
Why the EU Biotech Act must turn competitiveness ambition into reality - The Parliament Magazine
Google News – Clinical Trials External News
SRD-002 Gene Therapy Shows Sustained HFpEF Improvement at 12 Months - The Clinical Trial Vanguard
Google News – Clinical Trials External News
Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial - GlobeNewswire
Google News – Clinical Trials External News
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - PR Newswire
Google News – Clinical Trials External News
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - prnewswire.com
Google News – Clinical Trials External News
Novartis pauses trials of experimental cell therapy after three deaths - PharmaLive
Google News – Clinical Trials External News
Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Ocugen, Inc.
Google News – Clinical Trials External News
Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Yahoo Finance
Google News – FDA (biotech/pharma) External News
PharmaEssentia’s Besremi receives FDA approval for ET - Pharmaceutical Technology
Google News – FDA (biotech/pharma) External News